Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.
The Modification of Diet in Renal Disease (MDRD) formula is widely used in clinical practice to assess the correct drug dose. This formula is based on serum creatinine levels which might be influenced by chronic diseases itself or the effects of the chronic diseases. We conducted a systematic review...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4351004?pdf=render |
| _version_ | 1811221598259118080 |
|---|---|
| author | Willemijn L Eppenga Cornelis Kramers Hieronymus J Derijks Michel Wensing Jack F M Wetzels Peter A G M De Smet |
| author_facet | Willemijn L Eppenga Cornelis Kramers Hieronymus J Derijks Michel Wensing Jack F M Wetzels Peter A G M De Smet |
| author_sort | Willemijn L Eppenga |
| collection | DOAJ |
| description | The Modification of Diet in Renal Disease (MDRD) formula is widely used in clinical practice to assess the correct drug dose. This formula is based on serum creatinine levels which might be influenced by chronic diseases itself or the effects of the chronic diseases. We conducted a systematic review to determine the validity of the MDRD formula in specific patient populations with renal impairment: elderly, hospitalized and obese patients, patients with cardiovascular disease, cancer, chronic respiratory diseases, diabetes mellitus, liver cirrhosis and human immunodeficiency virus.We searched for articles in Pubmed published from January 1999 through January 2014. Selection criteria were (1) patients with a glomerular filtration rate (GFR) < 60 ml/min (/1.73 m2), (2) MDRD formula compared with a gold standard and (3) statistical analysis focused on bias, precision and/or accuracy. Data extraction was done by the first author and checked by a second author. A bias of 20% or less, a precision of 30% or less and an accuracy expressed as P30% of 80% or higher were indicators of the validity of the MDRD formula. In total we included 27 studies. The number of patients included ranged from 8 to 1831. The gold standard and measurement method used varied across the studies. For none of the specific patient populations the studies provided sufficient evidence of validity of the MDRD formula regarding the three parameters. For patients with diabetes mellitus and liver cirrhosis, hospitalized patients and elderly with moderate to severe renal impairment we concluded that the MDRD formula is not valid. Limitations of the review are the lack of considering the method of measuring serum creatinine levels and the type of gold standard used.In several specific patient populations with renal impairment the use of the MDRD formula is not valid or has uncertain validity. |
| first_indexed | 2024-04-12T08:03:30Z |
| format | Article |
| id | doaj.art-6e718ea355674885aba5e79c3b83a64e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T08:03:30Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-6e718ea355674885aba5e79c3b83a64e2022-12-22T03:41:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011640310.1371/journal.pone.0116403Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.Willemijn L EppengaCornelis KramersHieronymus J DerijksMichel WensingJack F M WetzelsPeter A G M De SmetThe Modification of Diet in Renal Disease (MDRD) formula is widely used in clinical practice to assess the correct drug dose. This formula is based on serum creatinine levels which might be influenced by chronic diseases itself or the effects of the chronic diseases. We conducted a systematic review to determine the validity of the MDRD formula in specific patient populations with renal impairment: elderly, hospitalized and obese patients, patients with cardiovascular disease, cancer, chronic respiratory diseases, diabetes mellitus, liver cirrhosis and human immunodeficiency virus.We searched for articles in Pubmed published from January 1999 through January 2014. Selection criteria were (1) patients with a glomerular filtration rate (GFR) < 60 ml/min (/1.73 m2), (2) MDRD formula compared with a gold standard and (3) statistical analysis focused on bias, precision and/or accuracy. Data extraction was done by the first author and checked by a second author. A bias of 20% or less, a precision of 30% or less and an accuracy expressed as P30% of 80% or higher were indicators of the validity of the MDRD formula. In total we included 27 studies. The number of patients included ranged from 8 to 1831. The gold standard and measurement method used varied across the studies. For none of the specific patient populations the studies provided sufficient evidence of validity of the MDRD formula regarding the three parameters. For patients with diabetes mellitus and liver cirrhosis, hospitalized patients and elderly with moderate to severe renal impairment we concluded that the MDRD formula is not valid. Limitations of the review are the lack of considering the method of measuring serum creatinine levels and the type of gold standard used.In several specific patient populations with renal impairment the use of the MDRD formula is not valid or has uncertain validity.http://europepmc.org/articles/PMC4351004?pdf=render |
| spellingShingle | Willemijn L Eppenga Cornelis Kramers Hieronymus J Derijks Michel Wensing Jack F M Wetzels Peter A G M De Smet Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review. PLoS ONE |
| title | Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review. |
| title_full | Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review. |
| title_fullStr | Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review. |
| title_full_unstemmed | Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review. |
| title_short | Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review. |
| title_sort | individualizing pharmacotherapy in patients with renal impairment the validity of the modification of diet in renal disease formula in specific patient populations with a glomerular filtration rate below 60 ml min a systematic review |
| url | http://europepmc.org/articles/PMC4351004?pdf=render |
| work_keys_str_mv | AT willemijnleppenga individualizingpharmacotherapyinpatientswithrenalimpairmentthevalidityofthemodificationofdietinrenaldiseaseformulainspecificpatientpopulationswithaglomerularfiltrationratebelow60mlminasystematicreview AT corneliskramers individualizingpharmacotherapyinpatientswithrenalimpairmentthevalidityofthemodificationofdietinrenaldiseaseformulainspecificpatientpopulationswithaglomerularfiltrationratebelow60mlminasystematicreview AT hieronymusjderijks individualizingpharmacotherapyinpatientswithrenalimpairmentthevalidityofthemodificationofdietinrenaldiseaseformulainspecificpatientpopulationswithaglomerularfiltrationratebelow60mlminasystematicreview AT michelwensing individualizingpharmacotherapyinpatientswithrenalimpairmentthevalidityofthemodificationofdietinrenaldiseaseformulainspecificpatientpopulationswithaglomerularfiltrationratebelow60mlminasystematicreview AT jackfmwetzels individualizingpharmacotherapyinpatientswithrenalimpairmentthevalidityofthemodificationofdietinrenaldiseaseformulainspecificpatientpopulationswithaglomerularfiltrationratebelow60mlminasystematicreview AT peteragmdesmet individualizingpharmacotherapyinpatientswithrenalimpairmentthevalidityofthemodificationofdietinrenaldiseaseformulainspecificpatientpopulationswithaglomerularfiltrationratebelow60mlminasystematicreview |